In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
Ideally, you should go to a natural holistic wellness clinic for consultation and maybe start on your weight loss journey as soon as you can, so that you are ready for Retatrutide when the moment it gets approved.
Phase 3 TRIUMPH-4 data showed 9mg achieved 26.4% weight loss versus 28.7% at 12mg over 68 weeks
The pancreatic effects of GLP-1 receptor activation in humans appear to be complex and likely influenced by individual patient factors, pre-existing pancreatic health, and concurrent metabolic conditions
The key finding is that GLP-1 can be detected in synovial fluid, Kragstrup said